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The pathogenicity of chicken anemia virus (CA V), as shown in previous studies, is 
the function of apoptotic mechanism as observed in chicken thymocytes and 
transformed chicken-Iymphoblastoid T cells. Thus the present study aimed to 
investigate the gene and its gene product responsible for apoptosis in as such that 
leads to the destruction of affected cells. It is known that apoptosis process is an 
important natural physiological mechanism that induces killing of cancer cells. 
Therefore, in theory, the gene or its gene product that is responsible for the apoptotic 
mechanism could be exploited especially in cancer therapy. In this study, a complete 
open reading frame (ORF) encoding VP3 protein was obtained from the DNA 
extracted from archival paraffin-embedded tissues and cloned into a plasmid vector. 
The sequencing of the full length of the ORF encoding VP3 protein showed that it 
was 363 base pairs long, which is similar in size to that of the reference CA V Cux-l 
strain. Comparison of the nucleotide sequences of this VP3 gene with that of the 
CA V Cux-l strain exhibited 98% sequence homology indicating that these two 
viruses are closely related. The functional characteristics of VP3 gene were further 
investigated by using an eukaryotic expression system, plasmid pcDNA 3.1/Zeo+. 
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The purified recombinant pcDNA-VP3 plasmid was used to transfect mammalian 
cells and cancer cells via electroporation. The induction of apoptosis, upon 
expression of VP3 gene, was studied by identifying and detecting morphological and 
biochemical changes due to apoptosis. Upon electron microscopic examination, 
typical apoptotic features were observed, which includes nuclear margination and 
formation of apoptotic bodies, as early as two days after transfection. Morphological 
changes developed due to apoptosis were obvious which were later confirmed by 
means of the apoptotic biochemical staining and DNA fragmentation assay. The 
differential activities of VP3 were further investigated by the use of the 
immunofluorescence technique. The VP3 protein was expressed and detected only in 
the cytoplasm of normal cells. In contrast, the expression of VP3 protein was 
localized particularly in the nucleus of the transformed cell lines (Vero and rat 
embryo fibroblast cells) and human derived breast cancer cells (MCF-7 and MDA­
MB 231). This differential cellular localization of VP3 protein in normal versus 
tumorigenic and transformed cells was the reason of VP3 specifically inducing 
apoptosis in transformed and cancerous cells but not in normal cells. The effects of 
VP3 protein expression in these three types of cells were also confirmed upon 
examination by confocal microscopy analysis with cells stained in propidium iodide 
and acridine orange stains. In conclusion, VP3 protein expression alone was able to 
induce apoptosis in transformed cells and in human derived cancer cells but had no 
effect on normal cells. The substantial evidences indicated that the DNA construct 
containing the VP3 gene under the control of human cytomegalovirus (hCMV) 
promoter, alias in the form of a DNA vaccine is the new potential candidate for anti­
cancer therapy. 
iv 
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia 
sebagai memenuhi keperluan ijazah Master Sains 
EKSPRESI GEN VP3 VIRUS ANEMIA A YAM YANG MENGARUH 
APOPTOSIS DALAM SEL-SEL YANG TERUBAH DAN SEL-SEL KANSER 
Oleh 
MOHAMED GHRICI 
Oktober 2001 
Pengerusi: Profesor Madya Mohd Azmi Mohd Lila, Ph.D. 
Fakulti: Perubatan Veterinar 
Sebagaimana yang telah ditunjukkan pada kajian terdahulu, permulaan 
pegembangan penyakit Virus Anemia Ayam (CA V) yang mempunyai fungsi 
mekanisma apoptotik yang terdapat dalam timosit-timosit ayam dan limphoblastoid 
sel-sel T ayarn yang terubah. Kajian ini bermatlarnat untuk menyiasat gen dan hasil 
keluaran gen yang bertanggung-jawab terhadap apoptosis seperti meningkatnya 
kerosakkan kepada sel-sel yang terjangkit. Sebagaimana yang diketahui, proses 
apoptosis adalah mekanisma fisiologikal semulajadi yang penting dalam mengaruh 
pembunuhan sel-sel kanser. Oleh itu secara teori, gen atau hasilan gen yang 
bertindakbalas bagi mekanisma apoptosis boleh dipergunakan terutamanya dalam 
pengubatan kanser. Dalam kajian ini, rangka bacaan terbuka yang lengkap CORP) 
yang mengekod protin VP3 telah diperolehi daripada DNA yang telah diekstrak dari 
tisu-tisu ditanam parafin dan diklonkan ke dalam vektor plasmid. Pada ketika 
pengklonan dan penurutan keseluruhan jarak gen ia telah menunjukkan rangka 
bacaan terbuka yang lengkap itu mengandungi 363 nukleotid dan menpunyai saiz 
yang sarna dengan strain rujukan Cux-l CAV. Gen yang didapati adalah 98 % 
homolgus (sarna siri) kepada strain rujukkan dan juga tinggi pengekalan dengan gen 
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VP3 dari lain-lain strain CA V. Ciri-ciri fungsi gen VP3 juga disiasat dangan 
menggunakan sistem expressi eukaryotik, pcDNA 3.11 Zeo + plasmid. Rekombinan 
plasmid pcDNA-VP3 yang telah ditulinkan telah digunakan terhadap sel mamalia 
transfeksi dan sel kanser melalui electroporasis. Apoptosis yang diaruhkan pada 
ketika expressi gen VP3 telah dikaji dengan mengenalpasti dan mengesan secara 
morfologi dan perubahan biokima yang disebabkan oleh apoptosis. Pada masa 
pemeriksaan microskop elektron transmisi, gambaran apoptosis yang tipikal telah 
dilihat termasuk pinggiran nuklear dan pembentukkan badan-badan apoptotik 
seawal-awal hari ke 2 selepas transfeksi. Perubahan morphologi terhasil disebabkan 
apoptosis kemudian ditentukan dengan pewamaan secara biokimia apoptotik dan 
asai pemotongan DNA. Aktiviti-aktiviti VP3 yang berbeza kemudiannya diselidik 
dengan menggunakan teknik immunofluoresen. Menarik sekali, dalam sel-sel 
normal, protin VP3 yang dikesan hanya bersetempat dalam sitoplasm dan tidak 
dalam lain-lain bahagian sel-sel transfeksi. Sebaliknya, pada ketika transfeksi, 
protein VP3 terdapat dalam nukleusnya (Vero dan Fibroblas embrio tikus) dan sel­
sel kanser payudara manusia. Kesan-kesan expresi protin VP3 dalam 3 jenis sel-sel 
ini juga telah di kenalpasti menerusi pemeriksaan analisa mikroskop konfokal 
dengan sel-sel yang diwamakan menerusi propidium iodida dan acridine oren. 
Kesimpulannya, expressi protin VP3 sahaja mampu untuk mengaruh apoptosis 
dalam sel-sel yang transfeksi dan sel payudara manusia tetapi tidak berkesan ke-atas 
sel-sel normal. Bukti-bukti yang kuat menunjukkan. DNA yang dibentuk 
mengandungi gen VP3 dibawah kawalan pemaju sitomegalovirus manusia (hCMV) 
dan dalam bentuk sebagai vaksin DNA adalah mempunyai potensi baru dalam 
pengubatan anti-kanser. 
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CHAPTER! 
INTRODUCTION 
The living organisms and the maintenance of their wellbeing and health are 
tribute to the equilibrium between cell division and apoptosis. The failure or 
dysregulation of one of these two fundamental mechanisms can be fatal or have serious 
pathological consequences (Singh et a!., 1994). Cellular death may occur either via 
apoptosis or necrosis. Necrosis is non-physiological or pathological type of cell death 
and it is uncontrolled in nature. It occurs following an extreme cell damage and is 
characterized by swelling and lysis of the cell causing the release of its content into the 
surrounding environment leading to inflammation (Trump et ai., 1991). 
Apoptosis differ from necrosis particularly by two dominant markers: 
morphological marker characterizing the structural changes of apoptotic cell and the 
biochemical marker characterizing the cleavage of DNA into domain-sized fragments 
(Walker et aI., 1993). Apoptosis is a programmed cell death and is a genetically 
controlled cellular mechanism of cell death to eliminate unwanted cells (Earnshaw, 
1995). Apoptosis is a widespread cellular mechanism involved in numerous processes 
such as the embryonic and neural development (Sanders and Wride, 1995), the 
regulation of the immune system (Williams, 1994), organogenesis and tissue 
homeostasis (Wyllie et aI., 1980). Some of the molecular and biochemical mechanisms 
of apoptosis have been elucidated and the research in this area continues to expand at an 
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extremely rapid rate following the development of new techniques and equipment (Hale 
et aI., 1996). 
The interest in apoptosis rise from the findings that apoptosis was involved in 
many important diseases such as neurodegenerative disorders, AIDS and particularly 
cancer, which affect millions of people around the globe. The growing amount of data 
generated through a continuous investigations of the mechanisms of apoptosis has 
proved to be very valuable in understanding the basic cell biology which will path the 
way to the development of very sensitive diagnostic tools and the design of therapies for 
various diseases. The suppression or failure andlor excessive rate of apoptosis can 
trigger the development of tumors as well as render the tumor cells resistant to the 
current chemotherapy and radiotherapy (Williams, 1994; Kerr et aI., 1994; Thompson, 
1995). 
The elucidation of the molecular mechanisms underlying apoptosis cannot be 
achieved without developing appropriate methods for detecting and characterizing 
apoptosis. Classically, the detection and characterization of apoptosis was based on the 
examination of morphological changes at the cellular level by light-electron-microscopy 
in combination with vital fluorescent dyes (McGahon et al., 1995). With the 
advancement of the technology new tools were designed to detect apoptosis at the 
molecular level, such as the use of Annexin V to monitor the loss of membrane 
phospholipid asymetry during apoptosis (Koopmans et al., 1993) or assays to detect 
DNA fragmentation by agarose gel electrophoresis (Wyllie. 1980), or by in-situ nick-
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end labeling (Gavrieli et al., 1992). Assays to measure the disruption of the 
mitochondrial transmembrane potential and the measurement of DNA and RNA content 
by flow cytometry were developed later (Darzynkiewicz et al., 1 992). Flow cytometry 
and its various alternatives are the most powerful methods to detect and quantitate 
apoptotic cells (Darzynkiewicz et aI., 1997) 
The important contribution of apoptosis research was made particularly in the 
field of oncology, where it was demonstrated that tumor was a consequence of failure or 
suppression of apoptosis, which also may render tumor cells more aggressive and 
resistant to chemotherapy and radiotherapy (Williams, 1991). Chemotherapeutic drugs 
and ionizing radiation, which are the only available cancer treatment, destroy the 
cancerous cells via apoptosis usually via the action of wild type p53 (Dive and Hikman, 
1991; Fisher, 1994; Thompson, 1995). These current therapies become hopeless when a 
mutation strike the p53 gene and/or by the over-expression of bcl-2 (Lowe et aI., 1 994). 
This problem may be solved by the use of a novel cancer therapy that would be 
independent to the present of prerequisite factors. VP3 protein is encoded by an avian 
virus (CAV) and has a length of 121 amino acids with an estimated size of 1 4  kDa 
(Notebom et at., 1 994). The chicken anemia virus (CA V) was first isolated in Japan in 
1979 (Yuasa et al., 1979) and was characterized as a new viral pathogen belonging to 
Circoviridae family (Studdert et aI., 1993).  In young chickens, CA V transiently cause 
severe anemia and immunodeficiency due to depletion of cortical thymocytes (Jeurissen 
et al., 1989; Yuasa et al., 1979). The depletion of thymocytes was demonstrated to 
